In closing, our observations suggest a model by which some threshold of HER2 expression and signaling are required for the formation and/or maintenance of a multi-protein complex that supports prolonged signaling from HER2/EGFR and HER2/HER3 heterodimers in breast cancer cells. The gene discussed is EGFR; the disease is breast carcinoma.